The Anxiolytics Market, a core segment within the global central nervous system (CNS) therapeutics space, is experiencing an accelerated growth phase, largely driven by the monumental global shift toward prioritizing mental health. Global anxiolytics market size was valued at USD 932.07 million in 2024 and is projected to reach USD 1325.50 million by 2032, with a CAGR of 4.5% during the...